Form 4: Health Catalyst CEO Sells Shares for Tax Obligations

Health Catalyst, Inc. CEO Daniel D. Burton sold 55,715 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Daniel D. Burton, CEO and Director of Health Catalyst, Inc. (HCAT), disposed of 55,715 shares of common stock.
• The transaction occurred on December 1, 2025, at a price of $2.9002 per share.
• This sale was a "sell to cover" transaction, mandated by the company's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs).
• The sale was not a discretionary trade by Mr. Burton.
• Following this transaction, Mr. Burton beneficially owns 1,393,099 shares of common stock.

Sentiment

Score: 6

Explanation: The transaction itself is neutral as it's a mandated 'sell to cover' for tax obligations. However, the underlying event of RSU vesting is a positive for the insider, indicating compensation realization.

Positives

• The underlying event is the vesting of Restricted Stock Units, which represents compensation for the CEO.

Negatives

• No discretionary negatives are associated with this transaction as the sale was mandated for tax purposes.

Future Outlook

NA

Industry Context

This is a routine insider transaction for tax purposes, common across all industries for executives receiving equity compensation. It does not reflect broader industry trends or specific competitive developments.

Stakeholder Impact

• Shareholders: The sale of shares by the CEO is a routine, non-discretionary event for tax purposes and is unlikely to have a significant impact on shareholder sentiment or the company's operational outlook.
• Employees: No direct impact on employees.

Key Dates

Keywords

Health Catalyst, HCAT, Daniel D. Burton, CEO, Director, Form 4, insider transaction, stock sale, restricted stock units, RSU vesting, sell to cover, tax withholding